Volume | 827,363 |
|
|||||
News | - | ||||||
Day High | 24.265 | Low High |
|||||
Day Low | 22.75 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Cullinan Therapeutics Inc | CGEM | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
23.76 | 22.75 | 24.265 | 23.17 | 23.81 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
13,199 | 827,363 | $ 23.35 | $ 19,316,278 | - | 7.64 - 30.1886 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
17:00:02 | 2 | $ 23.62 | USD |
Cullinan Therapeutics (CGEM) Options Flow Summary
Cullinan Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
997.4M | 43.07M | - | 0 | -153.16M | -3.56 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Cullinan Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CGEM Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 27.30 | 28.19 | 22.75 | 25.80 | 705,006 | -4.13 | -15.13% |
1 Month | 18.00 | 30.1886 | 15.20 | 24.64 | 1,275,780 | 5.17 | 28.72% |
3 Months | 17.59 | 30.1886 | 14.98 | 21.43 | 753,787 | 5.58 | 31.72% |
6 Months | 9.06 | 30.1886 | 7.64 | 18.82 | 531,387 | 14.11 | 155.74% |
1 Year | 9.13 | 30.1886 | 7.64 | 16.28 | 384,407 | 14.04 | 153.78% |
3 Years | 27.59 | 37.60 | 7.30 | 15.87 | 300,145 | -4.42 | -16.02% |
5 Years | 42.00 | 59.85 | 7.30 | 18.12 | 298,082 | -18.83 | -44.83% |
Cullinan Therapeutics Description
Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. |